Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Campath
Campath
Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia?
Motley Fool
Wed, 09/18/13 - 10:34 am
chronic lymphocytic leukemia
Sanofi
Campath
GSK
Arzerra
Roche
Rituxan
ibrutinib
Pharmacyclics
obinutuzumab
JNJ
Genmab
Sanofi pulls leukemia drug ahead of possible OK for Lemtrada
Reuters
Tue, 08/21/12 - 12:10 pm
Sanofi
Lemtrada
Campath
leukemia
Genzyme to push argument for Campath value
Yahoo/Reuters
Mon, 12/20/10 - 09:57 am
Campath
Genzyme
M&A
Sanofi
Termeer Touts Campath-Linked CVRs
InVivo
Sat, 11/27/10 - 12:59 pm
Henri Termeer
Campath
MS
Genzyme
multiple sclerosis
Sanofi
Genzyme Considers a Way Around Campath Impasse
WSJ Online
Mon, 11/22/10 - 10:31 am
Campath
Genzyme
multiple sclerosis
MS
Genzyme Says Campath MS Success Helps Justify Higher Sanofi Buyout Offer
Bloomberg
Thu, 10/14/10 - 05:19 pm
Genzyme
Campath
MS
multiple sclerosis
M&A
Sanofi
Genzyme sees signs of remission in 5-year MS drug data
Fierce Biotech
Thu, 10/14/10 - 11:53 am
MS
multiple sclerosis
Campath
Genzyme
Yet Another Reason That Sanofi-Genzyme Deal Will Go Through
BNET Pharma
Fri, 09/10/10 - 11:10 am
M&A
Sanofi
Genzyme
teriflunomide
MS
Campath
multiple sclerosis
Genzyme's Dilemma: Its Cheap Cancer Drug Wants to Cannibalize a Potential MS Blockbuster
BNET Pharma
Fri, 04/16/10 - 11:16 am
Genzyme
cancer
MS
multiple sclerosis
Campath
Positive MS data may thwart Icahn's plans for Genzyme
Fierce Biotech
Thu, 04/15/10 - 09:58 am
MS
multiple sclerosis
Campath
Carl Icahn
Genzyme
Genzyme sees MS drug topping efficacy league
Reuters
Wed, 04/14/10 - 01:59 pm
Genzyme
Campath
multiple sclerosis
MS
Genzyme completes cancer drug rights deal worth up to $1.25 billion to Bayer
Yahoo/AP
Tue, 06/2/09 - 08:41 am
Bayer
cancer
Genzyme
Campath
New study finds that Genzyme's drug Campath may be an effective treatment for multiple sclerosis
Businessweek
Tue, 02/10/09 - 06:08 am
multiple sclerosis
MS
Genzyme
Campath